Emerging roles of protein O-GlcNAcylation in cardiovascular diseases: Insights and novel therapeutic targets

IO Bolanle, K Riches-Suman, R Williamson… - Pharmacological …, 2021 - Elsevier
Cardiovascular diseases (CVDs) are the leading cause of death globally. While the major
focus of pharmacological and non-pharmacological interventions has been on targeting …
被引用次数：23 相关文章

Emerging roles of protein O-GlcNAcylation in cardiovascular diseases: Insights and novel therapeutic targets

IO Bolanle, K Riches-Suman… - Pharmacological …, 2021 - pubmed.ncbi.nlm.nih.gov
Cardiovascular diseases (CVDs) are the leading cause of death globally. While the major
focus of pharmacological and non-pharmacological interventions has been on targeting …

Emerging roles of protein O-GlcNAcylation in cardiovascular diseases: Insights and novel therapeutic targets.

IO Bolanle, K Riches-Suman, R Williamson… - Pharmacological …, 2021 - europepmc.org
Cardiovascular diseases (CVDs) are the leading cause of death globally. While the major
focus of pharmacological and non-pharmacological interventions has been on targeting …
[HTML] ferrostatin-1inhibitor.com

[HTML][HTML] OSMI-1

IO Bolanle, K Riches-Suman… - Pharmacological …, 2021 - ferrostatin-1inhibitor.com
Cardiovascular diseases (CVDs) are the leading cause of death globally. While the major
focus of pharmacological and non-pharmacological interventions has been on targeting …

Emerging roles of protein O-GlcNAcylation in cardiovascular diseases: Insights and novel therapeutic targets

IO Bolanle, K Riches-Suman, R Williamson, TM Palmer - 2021 - bradscholars.brad.ac.uk
Cardiovascular diseases (CVDs) are the leading cause of death globally. While the major
focus of pharmacological and non-pharmacological interventions has been on targeting …